Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kay Huebner

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Molecular Cancer Research : MCR|November 26, 2003
Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignanciesHideshi Ishii, Andrea Vecchione, Yutaka Furukawa, et al.
Plos One|February 8, 2014
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic optionsPierluigi Gasparini, Matteo Fassan, Luciano Cascione, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|January 18, 2017
Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expressionDaniel L Kiss, Catherine E Waters, Iman M Ouda, et al.
Cancer Research|February 27, 2015
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor InitiationDavid J Drasin, Anna L Guarnieri, Deepika Neelakantan, et al.
International Journal of Cancer|October 5, 2006
Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicityJoshua P Cantor, Dimitrios Iliopoulos, Atul S Rao, et al.
Journal of Proteome Research|March 8, 2014
Histone H1 phosphorylation in breast cancerSean W Harshman, Michael E Hoover, Chengsi Huang, et al.
Cell Death & Disease|February 17, 2019
Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cellsTeresa Druck, Douglas G Cheung, Dongju Park, et al.
Breast Cancer Research and Treatment|November 12, 2010
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical featuresGulnur Guler, Cigdem Himmetoglu, Rafael E Jimenez, et al.
Cancer Research|July 19, 2002
The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancersBruce C Turner, Michelle Ottey, Drazen B Zimonjic, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2017
Nit1 is a metabolite repair enzyme that hydrolyzes deaminated glutathioneAlessio Peracchi, Maria Veiga-da-Cunha, Tomiko Kuhara, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Molecular Cancer Research : MCR|November 26, 2003
Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignanciesHideshi Ishii, Andrea Vecchione, Yutaka Furukawa, et al.
Plos One|February 8, 2014
Androgen receptor status is a prognostic marker in non-basal triple negative breast cancers and determines novel therapeutic optionsPierluigi Gasparini, Matteo Fassan, Luciano Cascione, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|January 18, 2017
Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expressionDaniel L Kiss, Catherine E Waters, Iman M Ouda, et al.
Cancer Research|February 27, 2015
TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor InitiationDavid J Drasin, Anna L Guarnieri, Deepika Neelakantan, et al.
International Journal of Cancer|October 5, 2006
Epigenetic modulation of endogenous tumor suppressor expression in lung cancer xenografts suppresses tumorigenicityJoshua P Cantor, Dimitrios Iliopoulos, Atul S Rao, et al.
Journal of Proteome Research|March 8, 2014
Histone H1 phosphorylation in breast cancerSean W Harshman, Michael E Hoover, Chengsi Huang, et al.
Cell Death & Disease|February 17, 2019
Fhit-Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cellsTeresa Druck, Douglas G Cheung, Dongju Park, et al.
Breast Cancer Research and Treatment|November 12, 2010
Aberrant expression of DNA damage response proteins is associated with breast cancer subtype and clinical featuresGulnur Guler, Cigdem Himmetoglu, Rafael E Jimenez, et al.
Cancer Research|July 19, 2002
The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancersBruce C Turner, Michelle Ottey, Drazen B Zimonjic, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2017
Nit1 is a metabolite repair enzyme that hydrolyzes deaminated glutathioneAlessio Peracchi, Maria Veiga-da-Cunha, Tomiko Kuhara, et al.
Pageof 11